19-7698767-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001220500.2(FCER2):c.110G>A(p.Gly37Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000271 in 1,613,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001220500.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FCER2 | NM_001220500.2 | c.110G>A | p.Gly37Glu | missense_variant | 3/11 | ENST00000597921.6 | |
FCER2 | NM_002002.5 | c.110G>A | p.Gly37Glu | missense_variant | 3/11 | ||
FCER2 | NM_001207019.3 | c.107G>A | p.Gly36Glu | missense_variant | 2/10 | ||
FCER2 | XM_005272462.5 | c.110G>A | p.Gly37Glu | missense_variant | 3/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FCER2 | ENST00000597921.6 | c.110G>A | p.Gly37Glu | missense_variant | 3/11 | 1 | NM_001220500.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151988Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000645 AC: 16AN: 247874Hom.: 0 AF XY: 0.0000819 AC XY: 11AN XY: 134324
GnomAD4 exome AF: 0.000286 AC: 418AN: 1460958Hom.: 0 Cov.: 32 AF XY: 0.000264 AC XY: 192AN XY: 726752
GnomAD4 genome AF: 0.000125 AC: 19AN: 152106Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.110G>A (p.G37E) alteration is located in exon 3 (coding exon 2) of the FCER2 gene. This alteration results from a G to A substitution at nucleotide position 110, causing the glycine (G) at amino acid position 37 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at